AstraZeneca PLC (AZN)
184.45
+0.07
(+0.04%)
USD |
NYSE |
Nov 13, 16:00
185.00
+0.55
(+0.30%)
After-Hours: 19:59
AstraZeneca Price to Book Value : 12.09 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 12.09 |
| November 12, 2026 | 12.08 |
| November 11, 2026 | 12.15 |
| November 10, 2026 | 12.24 |
| November 09, 2026 | 12.41 |
| November 06, 2026 | 12.22 |
| November 05, 2026 | 12.24 |
| November 04, 2026 | 12.39 |
| November 03, 2026 | 12.05 |
| November 02, 2026 | 12.23 |
| October 30, 2026 | 12.23 |
| October 29, 2026 | 11.43 |
| October 28, 2026 | 11.11 |
| October 27, 2026 | 11.15 |
| October 26, 2026 | 11.27 |
| October 23, 2026 | 11.24 |
| October 22, 2026 | 11.31 |
| October 21, 2026 | 11.04 |
| October 20, 2026 | 11.06 |
| October 19, 2026 | 10.74 |
| October 16, 2026 | 10.84 |
| October 15, 2026 | 10.92 |
| October 14, 2026 | 10.62 |
| October 13, 2026 | 10.21 |
| October 12, 2026 | 10.38 |
| Date | Value |
|---|---|
| October 09, 2026 | 10.43 |
| October 08, 2026 | 10.40 |
| October 07, 2026 | 10.49 |
| October 06, 2026 | 10.39 |
| October 05, 2026 | 10.26 |
| October 02, 2026 | 10.28 |
| October 01, 2026 | 10.33 |
| September 30, 2026 | 10.58 |
| September 29, 2026 | 10.76 |
| September 28, 2026 | 10.89 |
| September 25, 2026 | 10.92 |
| September 24, 2026 | 10.78 |
| September 23, 2026 | 10.70 |
| September 22, 2026 | 11.03 |
| September 21, 2026 | 11.02 |
| September 18, 2026 | 10.88 |
| September 17, 2026 | 10.89 |
| September 16, 2026 | 10.67 |
| September 15, 2026 | 10.61 |
| September 14, 2026 | 10.73 |
| September 11, 2026 | 10.50 |
| September 10, 2026 | 10.46 |
| September 09, 2026 | 10.28 |
| September 08, 2026 | 10.49 |
| September 04, 2026 | 10.66 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| GSK Plc | 4.059 |
| Johnson & Johnson | 8.437 |
| Eli Lilly & Co. | 33.74 |
| Merck & Co., Inc. | 8.119 |
| Novo Nordisk A/S | 5.561 |
Price to Book Value Related Metrics
| PS Ratio | 9.522 |
| PEG Ratio | 1.629 |
| Price to Free Cash Flow | 71.53 |
| Price | 184.45 |
| Earnings Yield | 1.81% |
| Market Cap | 572.10B |
| PEGY Ratio | 1.549 |
| Operating PE Ratio | 40.99 |
| Normalized PE Ratio | 54.75 |